China, Sept. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Exploratory Study on ADC Combined with Immunotherapy in Recurrent Nasopharyngeal Carcinoma'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133348
Registration Time: 2026/09/24
Type: Interventional study
Primary Sponsor: Eye & ENT hospital of Fudan University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=320702
Published by HT Digital Content Services with permission from Health Daily Digest....